 |
Kirchgesner Julien; Beaugerie Laurent; Baumann Cédric; Baert Filip; Rahier Jean-François; Bergemalm Daniel; Cañete Fiorella; Caron Bénédicte; Cossignani Marta; Dias Sandra; Farkas Klaudia; Girod Parker; Goren Idan; Holvoet Tom; Krasz Susanne; Kumar Aditi; Rimmer Peter; Sheridan Juliette; Thut Jessica; Uzzan Mathieu; Viazis Nikos; Weimers Petra; Zagórowicz Edyta; Buisson Anne; Avedano Luisa; Rousseau Helene; Peyrin-Biroulet Laurent; Sebastian Shaji; Molnár Tamás; Szepes Zoltán; Nagy Ferenc; Bor Renáta; Bálint Anita; Fábián Anna; Rutka Mariann; Milassin Ágnes; et al.:
Building a Robust Investigator-Initiated Platform : The I-CARE Experience.
CLINICAL PHARMACOLOGY & THERAPEUTICS.
ISSN 0009-9236
(2026)
Anjie Suzanne I; D'Haens Geert R.; Baert Filip; Bossuyt Peter; Hoentjen Frank; Clasquin Esme; Molnár Tamás; Lowenberg Mark; Vermeire Severine; Panetta J. Carl; Dervieux Thierry:
Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease.
INFLAMMATORY BOWEL DISEASES, 32 (2).
pp. 390-393.
ISSN 1078-0998
(2026)
D'Haens Geert R; Löwenberg Mark; Baert Filip; Bossuyt Peter; Molnár Tamás; Hoentjen Frank; Clasquin Esmé; Gecse Krisztina B; Hulshoff Melanie S; De Hertogh Gert; Lenfant Matthias; Oldenburg Lotte; Vermeire Séverine:
Vedolizumab in early and late Crohn's disease (LOVE-CD) : a phase 4 open-label cohort study.
LANCET GASTROENTEROLOGY AND HEPATOLOGY, 11 (1).
pp. 12-21.
ISSN 2468-1253
(2026)
![[Fel]](/style/images/multi_up.png)
Vissza
